Welcome to the podcast.
I'm your host, Jaden Schaefer.
Today on the podcast, I wanna talk about a company called Lotus Health which has just raised 35 million.
And they have this thing where essentially this AI doctor is going to be seeing patients.
It's doing it for free.
It's kind of going viral on X for a bunch of different reasons.
So today on the podcast, I wanna break down what they're gonna be doing.
Is this the future of AI in healthcare?
Is this actually something that's going to get a lot of usage and kind of, where are people at with using AI for healthcare today?
So we're going to get into all of that on the podcast today.
Before we do, I wanted to mention if you've ever wanted to build an AI tool and you're not a developer like myself, I'm not a developer.
I created AIboxai, my own startup, where you can explain any tool or workflow you want to create, anything that you do on a repeated basis, and our tool can link together multiple ai models, input multiple prompts and create a tool that you can use to repeat that process over and over again.
In addition, just like chat gpt, we have a chat interface where you get access to over 40 of the top ai models, everything from Google Meta OpenAI, Anthropic 11, Labs for Audio, tons of cool image models.
All of it's on there for 20 bucks a month and you can chat with all of them in the same thread.
So you can switch between Anthropic for tone and OpenAI for research in the same thread, and it's 20 a month.
So I'll leave a link to that down in the description if you want to try that out.
I hope that saves you a ton of money not having to switch between different subscriptions and also a ton of time having everything in one central hub.
All right, let's get into the episode.
So the thing that I think is important to kind of preface all of this by saying is that today we have like a growing amount of people tons that are already going to things like ChatGPT and, you know, Anthropic and basically using those as a first stop for everything that you're doing, especially in health.
If you're going to be doing, you know, checking for symptoms, if you have medication questions.
I know for myself, when my kids are sick, I don't go to WebMD like I used to.
Also, I just feel like WebMD always would tell me that either you know there's no problem or I was going to die of cancer if I didn't immediately go to the emergency.
And so I just feel like it was sometimes, if you just put in your whatever your issues were, webmd had uh, some pretty extreme responses.
Chat gpt seems to be doing a really great job with that and i think what a lot of people find is that um, you know, these aren't doctors.
Chat gpt is not a doctor, but it can you have really really impressive medical context.
It asks really impressive, smart follow-up questions.
And I think it also helps the user.
Like if you're using it, it helps you articulate and say what your concerns are going to be.
And then some of these things which I thought was an interesting point I was talking to someone recently about, and they're like sometimes when you're using chat GPT and it has kind of these follow-up questions there, if you had like a really rushed appointment at the doctor, you might've missed some of some asking, some of these questions, some of your concerns, and so you could get all of that out to chat gpt.
There's been a ton of really interesting cases where people have been seeing specialists for many, many years, couldn't diagnose or figure out what their issue were, and they went to chat gpt, listed out just everything, had a conversation and it finds kind of these specialized um diagnoses which ended up being correct.
So it is a fantastic tool.
I think this is a really big behavioral shift.
And because of all of this, KJ Diwali is trying to build this new company, Lotus Health.
So his background is that he initially sold a dating app called D-Mill.
This is kind of a South Asian dating app.
He sold it back in 2019 for $50 million.
And after that his interest in healthcare, he said, is something that he's kind of always been curious about.
He said when he was a kid, he often acted as a translator for his parents during doctor visits.
And he said, because of that, that kind of showed him a lot of the early friction, the time pressure, a lot of the communication issues that were kind of baked into the US healthcare system.
And so he said, when modern LLMs arrived, when Chachapiti came out, He saw them less as this chatbot and more as an opportunity to kind of rebuild primary care from the ground up.
This was kind of his vision.
So he actually started the company in May of 2024, Lotus Health AI, and essentially he kind of just set this out.
It was like hey look, this is a free, always on.
It's like your primary care provider, but it's available 24 7 in 50 languages.
And this week he just announced 35 million dollars in a series a.
So the company is growing.
He's got some phenomenal investors uh, the round was led by crv and kleiner perkins, of course, top tier vc firm and that mean that totals up to, like his past raise plus the series a, about 41 million dollars is raised total for it.
Tons of people, i think, are already asking um ai about their health, and i think this was evidenced by the fact that openai just came out with openai help anthropic is doing something similar, and so i think lotus is kind of looking to go a little bit further than just conversational advice.
What they're trying to do is actually be designed as you know, something that can translate your chats into real clinical outcomes.
So you can go chat with it and it is gonna be able to give you a diagnosis and it's gonna be able to give you like prescriptions which is really crazy if you think about it, like the AI model will be able to prescribe you.
Um, it's going to be able to do lab orders and refer you to specialists.
Now i know there's probably a ton of uh, we'll talk about some of the compliance issues and like the craziness that goes into all of that, but if you think for a minute, you know what this would what, what the outcome of this would be diagnosis prescriptions, lab orders, referrals to specialists.
I mean, this is basically everything you need a primary care doctor for.
And so i think a lot of times, like i love the vision here, because a lot of times when you talk about like oh yeah, ai is like helping, It's like yeah, it can be like informational, but then you still have to go tell it call a doctor.
Like I, my wife and I have done many times, call a doctor, explain everything that chat GPT said.
They're like, okay, you're probably right.
And they move you along.
And it's like yeah, wouldn't it be phenomenal if I could have just talked to the AI and been able to go get the prescription and not have to pay someone and talk to someone because you know.
So I mean, I think that the hack nowadays is like you get those Teladoc apps and it's way cheaper than having to go to a doctor and you know, have to like schedule something.
Plus, like if you're sick with, like the flu, you don't want to go to a doctor anyways, or sick with something.
You don't want to have to go to a doctor and expose other people to the sickness.
So, I mean, honestly, I think this is a way better situation if you could do it.
Now, I think in practice, they're trying to operate like a full kind of like a medical practice.
They're not like, look, we're like a wellness app or something.
And they say that they hold licenses to operate in all 50 states.
They have malpractice insurance.
They run HIPAA compliant infrastructure and they have full access to all patient medical records.
So, I mean, they're really setting themselves up like an actual doctor's office.
I think the difference is that a lot of the frontline clinical work is going to be handled by this AI and it's essentially trained to ask the exact same questions and the same structure that your doctor would use during an intake.
So now for compliance and also just to make sure everything's super accurate.
They do always have a human in the loop on all of these things.
They have board-certified physicians from Stanford University, Harvard University, University of San Francisco, and they're reviewing all of the final diagnoses, all of the prescriptions and all of the lab requests before anything is actually issued to a patient right.
So there's always a kind of a person that still puts a stamp on this.
But Lotus has built their own clinical reasoning model and essentially it's going to go and grab all of the latest evidence-based medical research and it's also going to grab the patient's history and all of their responses and pull that all together in a way that is just so much more personalized and essentially it's really similar to what systems like open evidence are kind of like combining the retrieval of these like up-to-date studies with the structured clinical logic and put it all together.
This is what their ceo, dolly wall, said.
He said ai is giving the advice, but the real doctors are actually signing off on it.
So I think right now the company is like pretty upfront about what they don't handle.
They said they don't do anything urgent or you know emergent conditions that are.
All of that is kind of redirected to emergency rooms or an urgent care center.
Any cases that require physical exams are also put to in-person providers.
And then Lotus, they just position themselves as a replacement for the routine primary care access.
And so they're not saying like look, we're like a substitute for hands-on medicine or something like that.
Um, obviously super, super ambitious.
Um, there is a lot of regulatory risk that comes with that.
Healthcare in the U S is, you know, obviously kind of governed by a patchwork of state level licensing rules.
Um, and you know I like, know for, for in my own family I have an uncle that's a doctor and Moving when he, when his family moves, he's moved between many different states before and originally is from Canada and getting the licenses in every state and board certification approval.
Like there's a lot that goes into just a doctor moving between states, sometimes months or years for some of this stuff.
And so this is it's a complicated kind of process.
I think doctors are typically kind of restricted to treating patients only where they're licensed.
And if they want to move somewhere, then they have that whole issue, which I think is just another strain on the healthcare system that a system like this could help with and help alleviate.
So automating a big chunk of all of this kind of clinical decision-making has a bunch of, I think, additional scrutiny around liability.
There's safety and oversight that you have to think about.
But still, even with all of that, investors really believe that the timing's right.
Personally, I would agree with them on that. who is the CRV general partner.
So he joined the board and he was kind of the person like leading the charge over at CRV on this whole deal.
He is arguing that telemedicine infrastructure, which was kind of normalized during the pandemic, basically opened up the door for some of these new care models which are layered on top of AI.
He said, quote, there are many challenges, but it's not SpaceX sending astronauts to the moon.
He was also an early investor in like DoorDash, Mercury, and Ring.
And so he's basically framing Lotus as kind of a high conviction bet.
Primary care doctors right now are in short supply nationwide.
And so Lotus thinks that their model can handle up to 10 times as many patients as a traditional practice, even if they're still capping visits at about 15 minutes.
And it's interesting because it's like well, how come they could only do 10 times as many patients as a traditional practice?
And it's because they still have to hire actual doctors to review everything.
But with that, like with the same amount of doctors on their app versus an actual office, they can 10x that.
So they could hire a lot of doctors and basically get 10 times the output for people.
So Lotus definitely isn't alone in kind of going after this idea of an AI doctor.
There's a bunch of different competitors.
Lightspeed recently backed Doctrine.
There's a bunch of others.
For now, I think Lotus's kind of main competitor, like differentiator is price.
Their entire thing is free.
And of course, some people are like, well, how long can you sustain free?
I mean, they have licensed doctors reviewing these files, so i'm not sure if they're volunteering their time or lotus is just kind of taking a hit at the beginning to try to, you know, onboard more people.
Their ceo said that the future monetization options might include something like a subscription or sponsored programs, but right now they're intentionally postponing, like making money, just trying to get users, i think, and their immediate goal is to basically refine the product, build trust and just get as many patients using it as possible.
So In a you know, this is a healthcare system that is very used to long waits and kind of rushed visits.
And we hear a lot on the news about like doctors getting burnout and stuff.
And so I think, because of this, Lotus is basically betting that AI is kind of, you know, if you mix it with a human and you have a human kind of overseeing everything, you can turn what people are already doing informally into something that looks and feels like real care.
Like I already go to ChatGPT and ask all of these questions and put symptoms in.
And I mean, OpenAI knows that, that's why they launched OpenAI Health.
And so making this more formal and saying look, you had the whole conversation now, just like get it reviewed by a doctor and you can go get your prescription, I think is a very, very smart direction.
I'm excited to see what happens with this company and I'll keep you guys all up to date on it in the future.
Thanks so much for tuning into the podcast.
Make sure to go check out AIboxai if you want to get all of the top AI models in one place for 20 a month.
There's a link in the description to AIbox.ai.
Thanks so much for tuning in and I'll catch you in the next episode.
